A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial

Wei-Chen Tai, Chih-Ming Liang, Kuo-Wei Bi, Chung-Mou Kuo, Lung-Sheng Lu, Cheng-Kun Wu, Shih-Cheng Yang, Yuan-Hung Kuo, Chen-Hsiang Lee, Chih-Fang Huang, Chien-Ning Hsu, Pin-I Hsu, Deng-Chyang Wu, Tsung-Hui Hu, Keng-Liang Wu, Seng-Kee Chuah
  • Infection and Drug Resistance, September 2019, Taylor & Francis
  • DOI: 10.2147/idr.s213998

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2147/idr.s213998

The following have contributed to this page: Dr KENG-LIANG WU and Seng-Kee Chuah